2
views
0
recommends
+1 Recommend
0 collections
    0
    shares
      • Record: found
      • Abstract: found
      • Article: found
      Is Open Access

      Adrenocorticotropic Hormone Secreting Pheochromocytoma Underlying Glucocorticoid Induced Pheochromocytoma Crisis

      case-report

      Read this article at

      Bookmark
          There is no author summary for this article yet. Authors can add summaries to their articles on ScienceOpen to make them more accessible to a non-specialist audience.

          Abstract

          Context

          Pheochromocytomas are hormone secreting tumors of the medulla of the adrenal glands found in 0.1–0.5% of patients with hypertension. The vast majority of pheochromocytomas secrete catecholamines, but they have been occasionally shown to also secrete interleukins, calcitonin, testosterone, and in rare cases adrenocorticotropic hormone. Pheochromocytoma crisis is a life threatening event in which high levels of catecholamines cause a systemic reaction leading to organ failure.

          Case Description

          A 70-year-old man was admitted with acute myocardial ischemia following glucocorticoid administration as part of an endocrine workup for an adrenal mass. Cardiac catheterization disclosed patent coronary arteries and he was discharged. A year later he returned with similar angina-like chest pain. During hospitalization, he suffered additional events of chest pain, shortness of breath, and palpitations following administration of glucocorticoids as preparation for intravenous contrast administration. Throughout his admission, the patient demonstrated both signs of Cushing's syndrome and high catecholamine levels. Following stabilization of vital parameters and serum electrolytes, the adrenal mass was resected surgically and was found to harbor an adrenocorticotropic hormone secreting pheochromocytoma. This is the first documented case of adrenocorticotropic hormone secreting pheochromocytoma complicated by glucocorticoid induced pheochromocytoma crisis.

          Conclusion

          Care should be taken when administering high doses of glucocorticoids to patients with suspected pheochromocytoma, even in a patient with concomitant Cushing's syndrome.

          Related collections

          Most cited references15

          • Record: found
          • Abstract: found
          • Article: not found

          Cushing Syndrome Due to ACTH-Secreting Pheochromocytoma, Aggravated by Glucocorticoid-Driven Positive-Feedback Loop.

          Pheochromocytoma is a catecholamine-producing tumor that originates from adrenal chromaffin cells and is capable of secreting various hormones, including ACTH.
            Bookmark
            • Record: found
            • Abstract: not found
            • Article: not found

            THE PITUITARY BODY AND ITS DISORDERS. CLINICAL STATES PRODUCED BY DISORDERS OF THE HYPOPHYSIS CEREBRI

              Bookmark
              • Record: found
              • Abstract: found
              • Article: not found

              Pheochromocytoma crisis induced by glucocorticoids: a report of four cases and review of the literature.

              Pheochromocytoma crisis (PC) is a rare life-threatening endocrine emergency that may present spontaneously or can be unmasked by 'triggers', including certain medications that provoke the release of catecholamines by tumors. Several isolated cases of PC have been reported after administration of exogenous glucocorticoids; evidence that these drugs cause adverse events in patients with pheochromocytoma is mainly anecdotal.
                Bookmark

                Author and article information

                Contributors
                Journal
                Case Rep Endocrinol
                Case Rep Endocrinol
                CRIE
                Case Reports in Endocrinology
                Hindawi
                2090-6501
                2090-651X
                2018
                20 February 2018
                : 2018
                : 3963274
                Affiliations
                1The Hebrew University Hadassah Medical School, Hadassah-Hebrew University Medical Center, Jerusalem, Israel
                2Endocrinology & Metabolism Service, Hadassah-Hebrew University Medical Center, Jerusalem, Israel
                3Department of General Surgery, Hadassah-Hebrew University Medical Center, Jerusalem, Israel
                4Department of Pathology, Hadassah-Hebrew University Medical Center, Jerusalem, Israel
                5Nephrology and Hypertension Services, Hadassah-Hebrew University Medical Center, Jerusalem, Israel
                6Department of Internal Medicine, Hadassah-Hebrew University Medical Center, Jerusalem, Israel
                Author notes

                Academic Editor: Toshihiro Kita

                Author information
                http://orcid.org/0000-0002-0322-8348
                http://orcid.org/0000-0002-8425-1776
                http://orcid.org/0000-0002-4160-4965
                Article
                10.1155/2018/3963274
                5838465
                59e2904c-30a1-40d5-b631-521c514112bd
                Copyright © 2018 Gil A. Geva et al.

                This is an open access article distributed under the Creative Commons Attribution License, which permits unrestricted use, distribution, and reproduction in any medium, provided the original work is properly cited.

                History
                : 22 December 2017
                : 19 January 2018
                : 23 January 2018
                Categories
                Case Report

                Comments

                Comment on this article